Publikationen im NUM

Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.

Demichev V, et al . A time-resolved proteomic and prognostic map of COVID-19. Cell Systems. 2021;      [DOI] 
Brümmer L, Katzenschlager S, Gaeddert M, others . Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. PLOS Medicine. 2021; 18(8):      [DOI]      [Datei] 
Stanifer ML, Boulant S. Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 (BSL-3) Conditions. JoVE. 2021; (166):e62857.      [DOI] 
Mürbe D, Kriegel M, Lange J, et al . Aerosol emission in professional singing of classical music. Sci Rep. 2021; 11      [DOI] 
Mürbe D, Kriegel M, Lange J, et al . Aerosol emission of adolescents voices during speaking, singing and shouting. PLoS ONE. 2021; 16(2):      [DOI] 
Schwartz J, Reuters MC, Schallenburger M, others . Allgemeine Palliativversorgung in Pandemiezeiten. Onkologe. 2021; 27686-690.      [DOI] 
Weber JP, Tielker JM, Kamandi N, et al . Ambulante Betreuung onkologischer Patienten in palliativer Behandlungssituation und ihrer Angehörigen in der COVID-19-Pandemie. Onkologe. 2021; 27783-789.      [DOI] 
Priesemann V, Balling R, Brinkmann MM, Ciesek S, Czypionka T, Eckerle I, Giordano G, Hanson C, Hel Z, Hotulainen P, Klimek P, Nassehi A, Peichl A, Perc M, Petelos E, Prainsack B, Szczurek E. An action plan for pan-European defence against new SARS-CoV-2 variants. The Lancet. 2021; 397(10273):469—470.      [DOI] 
Bagheri G, Thiede B, Hejazi B, et al . An upper bound on one-to-one exposure to infectious human respiratory particles. PNAS. 2021; 118(49):      [DOI] 
Schulze J, Mache C, Balazs A, Frey D, Niemeyer D, Olze ea. Analysis of SARS-CoV-2 replication in explant cultures of the human upper respiratory tract reveals broad tissue tropism of wild-type and B.1.1.7 variant viruses. J Infect Dis. 2021;      [DOI] 
Renn M, Bartok E, Zillinger T, Hartmann G, Behrendt R. Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions. Pharmacology & Therapeutics. 2021; 107931.      [DOI] 
Gagiannis D, Umathum VG, Bloch W, Rother C, Stahl M, Witte HM, Djudjaj S, Boor P, Steinestel K. Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2. Am J Clin Pathol. 2021;      [DOI] 
Nikolai O, Rohardt C, Tobian F, et al . Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter?. Infect Dis. 2021; 53(12):      [DOI]      [Datei] 
Popp M, Stegemann M, Riemer M, Metzendorf M, Romero CS, Mikolajewska A, Kranke P, Meybohm P, Skoetz N, Weibel S. Antibiotics for the treatment of COVID‐19. Cochrane Database of Systematic Reviews. 2021; 2021CD015025.      [DOI] 
Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller J, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica. 2021 Aug.; 106(8):2170-2179.      [DOI] 
Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel ea. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurol. 2021; 78948—960.
Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel H, Büttnerova I, Elezkurtaj S, Scheibe F, Radke J, Meisel C, Drosten C, Radbruch H, Heppner F, Corman V, Stenzel W. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurol. 2021 Aug.; 78(8):948-960.      [DOI] 
Adorjan K, Pogarell O, Pröbstl L, Rüb M, Wiegand HF, Tüscher O, Lieb K, Wassiliwizky E, Gerlinger G, Heinz A, Falkai P. Auswirkungen der COVID-19-Pandemie auf die Versorgungssituation in psychiatrischen Kliniken in Deutschland. Der Nervenarzt. 2021; 92(6):562—570.      [DOI] 
Klüpfel J, Koros RC, Dehne K, et al . Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA). Anal Bioanal Chem. 2021; 413(22):      [DOI] 
Evert K, Dienemann T, Brochhausen C, Lunz D, Lubnow M, Ritzka M, Keil F, Trummer M, Scheiter A, Salzberger B, others . Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Virchows Arch. 2021; 1-12.      [DOI] 
Arora P, et al . B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination. Cell Reports. 2021; 109825.      [DOI] 
Bartenschlager C, Römmele C, Temizel S. Befragung zum Besuchsmanagement: Wie Pflegeeinrichtungen Besuche während der COVID-19-Pandemie organisierten. Protzenziale digitaler Systeme kaum genutzt. CAREkonkret. 2021; 32/33     [Datei] 
Kumar S, Çalışkan D, Janowski J, Faist A, Conrad B, Lange ea. Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics. Front Immunol. 2021; 12752227.
Traxler S, Schindler M, Bösmüller H, Klingel K. Biologie und Pathologie von Coronaviren [Biology and pathology of coronaviruses]. Pathologe. 2021; 42(2):149-154.
Swoboda J, Wittschieber D, Sanft J, Kleemann S, Elschner S, Ihle H, Hubig M, Pletz M, Mall G, Gassler N. Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2. Histopathology. 2021 Apr.; 78(5):727-737.      [DOI] 
Burns J, Movsisyan A, Rehfuess E, Stratil J. Border control and SARS-CoV-2: an opportunity for generating highly policy-relevant, real-world evidence. Journal of Travel Medicine. 2021; 1—3.      [DOI] 
Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, Giordano G, Hanson C, Hens N, Iftekhar E, Klimek P, Kretzschmar M, Peichl A, Perc M, Sannino F, Schernhammer E, Schmidt A, Staines A, Szczurek E. Call for a pan-European COVID-19 response must be comprehensive – Authors‘ reply. The Lancet. 2021; 397(10284):1541.      [DOI] 
Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, Giordano G, Gurdasani D, Hanson C, Hens N, Iftekhar E, Kelly-Irving M, Klimek P, Kretzschmar M, Peichl A, Perc M, Sannino F, Schernhammer E, Schmidt A, Staines A, Szczurek E. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. The Lancet. 2021; 397(10269):92—93.      [DOI] 
Bräuninger H, Stoffers B, Fitzek A, et al . Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart. Cardiovasc Res. 2021; cvab322.      [DOI] 
Doehn J, Tabeling C, Biesen R, Saccomanno J, Madlung E, Pappe E, Gabriel F, Kurth F, Meisel C, Corman V, others . CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection. 2021; 49(4):757—762.      [DOI] 
Walker A, Houwaart T, Finzer P, et al . Characterization of SARS-CoV-2 genetic structure and infection clusters in a large German city based on integrated genomic surveillance, outbreak analysis, and contact tracing. Epidemiology. 2021;      [DOI]      [Datei] 
Walker A, Houwaart T, Finzer P, et al . Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting. Clin Infect Dis. 2021; 74(6):      [DOI] 
Ankerhold J, Giese S, Kolb P, et al . Circulating multimeric immune complexes drive immunopathology in COVID-19. Immunology. 2021;      [DOI] 
Thibeault C, Mühlemann B, Helbig E, Mittermaier M, Lingscheid T, Tober-Lau P, Meyer-Arndt L, Meiners L, Stubbemann P, Haenel S, others . Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021; 49(4):703—714.      [DOI] 
Thibeault C, et al . Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021;      [DOI] 
Mikolajewska A, Fischer A, Piechotta V, Mueller A, Metzendorf M, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID‐19. Cochrane Database of Systematic Reviews. 2021; 2021CD015045.      [DOI] 
Ochs M, Timm S, Elezkurtaj S, Horst D, Meinhardt J, Heppner ea. Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient. Eur Respir J. 2021; 57      [DOI] 
Herbst K, Meurer M, Kirrmaier D, others . Colorimetric RT-LAMP and LAMP-sequencing for Detecting SARS-CoV-2 RNA in Clinical Samples. BIO-Protocols. 2021; 11(6):      [DOI]      [Datei] 
Brunotte L, Zheng S, Mecate-Zambrano A, Tang J, Ludwig S, Rescher ea. Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro. Pharmaceutics. 2021; 13
Müller A, Engler F, Schütze D, Nohl-Deryk P, Güthlin C. Communication experience by secure instant messaging during the Covid-19 pandemic for general practitioners and public health workers – a qualitative analysis. Doc21dkvf051. 2021;      [DOI] 
Osterman A, Iglhaut M, Lehner A, Späth P, Stern M, Autenrieth H, Muenchhoff M, Graf A, Krebs S, Blum H, Baiker A, Grzimek-Koschewa N, Protzer U, Kaderali L, Baldauf H, Keppler OT. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern. Medical microbiology and immunology. 2021; 210(5-6):263—275.      [DOI] 
Osterman A, Iglhaut M, Lehner A, et al . Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern. Med Microbiol Immunol. 2021; 210      [DOI] 
Georg P, et al . Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2021;      [DOI] 
Georg P, Astaburuaga-García R, Bonaguro L, et al . Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2021;      [DOI] 
Föh B, Borsche M, Balck A, et al . Complications of nasal and pharyngeal swabs – a relevant challenge of the COVID-19 pandemic?. Eur Respir J. 2021;      [DOI] 
Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review. Cochrane Database of Systematic Reviews. 2021; 2021CD013600.      [DOI] 
Beierle F, et al . Corona Health—A Study- and Sensor-Based Mobile App Platform Exploring Aspects of the COVID-19 Pandemic. Int J Environ Res Public Health. 2021; 187395.      [DOI] 
Steudte-Schmiedgen S, Stieler L, Erim Y, Morawa E, Geiser F, Beschoner P, Jerg-Bretzke L, Albus C, Hiebel N, Weidner K. Correlates and Predictors of PTSD Symptoms Among Healthcare Workers During the COVID-19 Pandemic: Results of the egePan-VOICE Study. Frontiers in Psychiatry. 2021; 12      [DOI]      [Datei] 
Ebigbo A, Römmele C, Bartenschlager C, et al . Cost-effectiveness analysis of SARS-CoV-2 infection prevention strategies including pre-endoscopic virus testing and use of high risk personal protective equipment. Endoscopy. 2021; 53(2):      [DOI] 
Baumann M. COVID-19 and mental health in children and adolescents: a diagnostic panel to map psycho-social consequences in the pandemic context. Discov Ment Health. 2021; 1(1):2.      [DOI]